MKI67 and neoplasm: Also, we compared BRCA mutation-positive and negative cancers in terms of standard clinico-pathological prognostic factors; we found no significant differences in tumor size, pathological grade, Ki67 scores, or molecular subtypes (Supplementary Table S1).